Skip to content

Effect Of Nicotine on Neurocognitive Performance of Cigarette Smokers

Effect Of Nicotine on Neurocognitive Performance of Cigarette Smokers: A Double-Blind, Within-Subjects, Placebo-Controlled Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00429208
Enrollment
40
Registered
2007-01-31
Start date
2007-02-28
Completion date
2007-04-30
Last updated
2007-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nicotine Dependence, Nicotine Use Disorder, Smoking, Tobacco Use Disorder

Keywords

Nicotine Dependence, Smoking, Tobacco Use Disorder, Nicotine Use Disorder

Brief summary

This research project addresses the hypothesis that a neurocognitive profile characterized by impairment of response inhibition and sustained attention may be a risk factor for smoking initiation and nicotine dependence among young women. Nicotine has short- term, facilitating effects on attention and response inhibition. Therefore, individuals who are impaired on cognitive functions such as these and initiate cigarette smoking may be more likely to maintain the habit and develop nicotine dependence. The research protocol specifically tests whether administration of nicotine to non-abstinent, regular cigarette smokers improves cognitive function in those domains where the participants had previously been shown to manifest performance deficits

Interventions

DRUGNicotine

Sponsors

Hadassah Medical Organization
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
DOUBLE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Reported smoking cigarettes on a daily basis at the time of the original study and continue to smoke currently * Manifested poor performance on the MFFT (The neurocognitive test that yielded differences between smokers and non-smokers) * Competent and willing to give written informed consent

Exclusion criteria

* Pregnancy, breast-feeding, non-use of contraception such that the possibility of pregnancy cannot be excluded * Intake of any medication that may potentially interact with nicotine. * Any current or past medical condition that represents a contra-indication to nicotine administration.

Design outcomes

Primary

MeasureTime frame
Neurocognitive functions

Countries

Israel

Contacts

Primary ContactAvi Yakir, MD
yakir@hadassah.org.il00 972 2 6777184
Backup ContactHadas Lemberg, PhD
lhadas@hadassah.org.il00 972 2 6777572

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026